Abstract
We analyzed whether institutions training physicians and advanced practice registered nurses (APRNs) have conflict of interest policies (COIP) specific to pharmaceutical relationships and if present do such policies extend to students, other clinicians, personnel, sites, and curriculum. The 2014 Association of Academic Health Centers list of US members (n=92) identified 65 eligible universities. A 10-item web-based survey was distributed to potential participants. Initial contact was to institutional Directors of Nursing Research, with sequential contacts if no response to Nursing Deans or Department Chairs, Clinical Placement Coordinators, Institutional Research Board Directors, Bioethics Departments, and Legal Counsel. Contacts received 2 email reminders before initiating the next level of contact. Reminder postcards were sent to Dean or Department Chair non-responders. 20 institutions fully completed the survey, a 30% response. Most (90%) reported COIP for continuing education or industry funded speaking but 40.5% were "unsure" or "unclear" whether this included curriculum. 55.6% were "unsure" or "did not know" if preceptors were included. Website confirmation noted COIP most frequently covered research funding or trials (95%) or gifts and meals (90%). Policies least frequently covered curriculum (10%). 25% included all clinicians in their COIP. No institution covered clinical preceptors unless they were employees. Gaps exist in knowledge of COIP and their scope related to the education of nurse prescribers. While most policies cover research funding or trials in accordance with federal law, they are not explicit or known regarding their extension to nonphysician clinicians, curriculum, or preceptors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Association of Colleges of Nursing. (2006). The essentials of doctoral education for advanced nursing practice. Washington D.C.: Author.
American Association of Medical Colleges (2008). Protecting patients, preserving integrity, advancing health: Accelerating the Implementation of COI Policies in Human Subjects Research Retrieved from: https://members.aamc.org/eweb/upload/Protecting%20Patients,%20Preserving%20Integrity.pdf.
American Association of Nurse Practitioners (2017). State practice environment. Retrieved from: https://www.aanp.org/legislation-regulation/state-legislation/state-practice-environment .
American Medical Student Association (2017). 2016 AMSA scorecard. Retrieved from: https://www.amsa.org/scorecard/.
Austad, K. E., Avorn, J., Franklin, J. M., Kowal, M. K., Campbell, E. G., & Kesselheim, A. S. (2013). Changing interactions between physician trainees and the pharmaceutical industry: A national survey. Journal of General Internal Medicine, 28(8), 1064–1071.
Avorn, J. (2017). Academic detailing:“marketing” the best evidence to clinicians. JAMA, 317(4), 361–362.
Babor, T. F., & Robaina, K. (2013). Public health, academic medicine, and the alcohol industry’s corporate social responsibility activities. American Journal of Public Health, 103(2), 206–214.
Bill and Melinda Gates Foundation (2015). Conflict of interest policy. Author. Retrieved from: http://www.gatesfoundation.org/Jobs/Conflict-of-Interest.
Brazeau, C. M., Shanafelt, T., Durning, S. J., Massie, F. S., Eacker, A., Moutier, C., et al. (2014). Distress among matriculating medical students relative to the general population. Academic Medicine, 89(11), 1520–1525.
Brennan, T. A., Rothman, D. J., Blank, L., Blumenthal, D., Chimonas, S. C., Cohen, J. J., et al. (2006). Health industry practices that create conflicts of interest: A policy proposal for academic medical centers. JAMA, 295(4), 429–433.
Carlat, D., Bergh, S., & Carroll, S. (2013). Conflict-of-interest policies for academic medical centers: Recommendations for best practices. Philadelphia, PA: Pew Charitable Trusts.
Carlat, D. J., Fagrelius, T., Ramachandran, R., Ross, J. S., & Bergh, S. (2016). The updated AMSA scorecard of conflict-of-interest policies: a survey of US medical schools. BMC Medical Education, 16(1), 202.
Center for Medicare and Medicaid Services (2014). Open Payments Act 2014, 79 Fed. Reg. 219 (November 13, 2014). Retrieved from: https://www.cms.gov/OpenPayments/Downloads/Open-Payments-Revision-Nov-2014.pdf.
Centers for Medicare and Medicaid Services (2013). 78 Fed. Reg. 42 CFR Parts 402 and 403. Medicare, Medicaid, Children's Health Insurance Programs; Transparency Reports and Reporting of Physician Ownership or Investment Interests. Retrieved from: https://www.cms.gov/Regulations-and-Guidance/Legislation/National-Physician-Payment-Transparency-Program/Downloads/Final-Rule.pdf.
Chimonas, S., Patterson, L., Raveis, V. H., & Rothman, D. J. (2011). Managing conflicts of interest in clinical care: A National Survey of policies at U.S. medical schools. Academic Medicine, 86(3), 293–299. https://doi.org/10.1097/ACM.0b013e3182087156.
Commonwealth of Massachusetts (2017). General laws, Part I, Title XVI, Chapter 111N. Retrieved from: https://malegislature.gov/Laws/GeneralLaws/PartI/TitleXVI/Chapter111N.
Crigger, N., Barnes, K., Junko, A., Rahal, S., & Sheek, C. (2009). Nurse practitioners’ perceptions and participation in pharmaceutical marketing. Journal of Advanced Nursing, 63(3), 525–533. https://doi.org/10.1111/j.1365-2648.2008.04911.x.
Department of Veterans Affairs (2016). Advanced Practice Registered Nurses, 81 Fed. Reg. 240 (December 14, 2016). Retrieved from: https://www.gpo.gov/fdsys/pkg/FR-2016-12-14/pdf/2016-29950.pdf.
Diethelm, P. A., Rielle, J., & McKee, M. (2005). Links with the tobacco industry. Lancet, 365, 211–212.
Dyrbye, L. N., & Shanafelt, T. D. (2011). Commentary: Medical student distress: A call to action. Academic Medicine, 86(7), 801–803.
Epstein, A. J., Busch, S. H., Busch, A. B., Asch, D. A., & Barry, C. L. (2013). Does exposure to conflict of interest policies in psychiatry residency affect antidepressant prescribing? Medical Care, 51(2), 199–203.
European Federation of Pharmaceutical Industries and Associations (2017). Retrieved from: https://www.efpia.eu/.
Federal Trade Commission (2014). Policy perspectives: Competition and the regulation of advanced practice nurses. (author). Retrieved from: http://www.ftc.gov/system/files/documents/reports/policy-perspectives-competition-regulation-advanced-practice-nurses/140307aprnpolicypaper.pdf.
Field, M. J., & Lo, B. (Eds.). (2009). Conflict of interest in medical research, education, and practice. Washington, DC: National Academies Press.
Fischer, M. A., Keough, M. E., Baril, J. L., Saccoccio, L., Mazor, K. M., Ladd, E., et al. (2009). Prescribers and pharmaceutical representatives: Why are we still meeting? Journal of General Internal Medicine, 24(7), 795–801.
Grundy, Q. (2012). The physician payments sunshine act and the unaddressed role of nurses: An interest group analysis. Policy, Politics & Nursing Practice, 13(3), 154–161. https://doi.org/10.1177/1527154412465196.
Grundy, Q., Bero, L., & Malone, R. (2013). Interactions between non-physician clinicians and industry: A systematic review. PLoS Medicine, 10(11), e1001561. https://doi.org/10.1371/journal.pmed.1001561.
Joint Commission (2017). Is my hospital an academic medical center hospital? Retrieved from: http://www.jointcommissioninternational.org/achieve/academic-medical-center-hospitals-1/.
Kao, A. C., Braddock III, C., Clay, M., Elliott, D., Epstein, S. K., Filstead, W., et al. (2011). Effect of educational interventions and medical school policies on medical students' attitudes toward pharmaceutical marketing practices: A multi-institutional study. Academic Medicine, 86(11), 1454–1462.
King, M., & Bearman, P. S. (2017). Gifts and influence: Conflict of interest policies and prescribing of psychotropic medications in the United States. Social Science & Medicine, 172, 153–162.
King, M., Essick, C., Bearman, P., & Ross, J. S. (2013). Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: Difference-in-differences analysis. BMJ, 346(5), f264. https://doi.org/10.1136/bmj.f264.
Ladd, E., & Hoyt, A. (2016). Shedding light on nurse practitioner prescribing. The Journal for Nurse Practitioners, 12(3), 166–173.
Larkin, I., Ang, D., Steinhart, J., Chao, M., Patterson, M., Sah, S., et al. (2017). Association between Academic Medical Center pharmaceutical detailing policies and physician prescribing. JAMA, 317(17), 1785–1795.
Legislative Assembly of Ontario (2017). Bill 160, 2nd session, 41st legislature. An act to amend, repeal, and enact various acts in the interest of strengthening quality and accountability for patients. Retrieved from http://www.ontla.on.ca/bills/bills-files/41_Parliament/Session2/b160_e.pdf.
National Organization of Nurse Practitioner Faculties (2017). 2017 nurse practitioner core competencies with curriculum content. Available at: http://c.ymcdn.com/sites/www.nonpf.org/resource/resmgr/competencies/2017_NPCoreComps_with_Curric.pdf.
Pew Charitable Trusts (2013). Conflicts-of-interest policies for academic medical centers: Recommendations for best practices. Available at: http://www.pewtrusts.org/en/research-and-analysis/reports/0001/01/01/conflictsofinterest-policies-for-academic-medical-centers.
Psaty, B. M., & Rennie, D. (2006). Clinical trial investigators and their prescribing patterns: Another dimension to the relationship between physician investigators and the pharmaceutical industry. Journal of the American Medical Association, 295(23), 2787–2790.
Rest, J., Narvaez, D., Bebeau, M., & Thoma, S. (1999). DIT-2: Devising and testing a new instrument of moral judgment. Journal of Educational Psychology, 91(4), 644–659. https://doi.org/10.1037/0022-0663.91.4.644.
Rosenbaum, L. (2015). Understanding bias: The case for careful study. New England Journal of Medicine, 372(20), 1959–1963. https://doi.org/10.1056/NEJMms1502497.
State of Conneticut (2014). An act concerning the governor’s recommendations to improve access to health care. Public act 14-12. Retrieved from: http://www.cga.ct.gov/2014/ACT/PA/2014PA-00012-R00SB-00036-PA.htm.
State of Minnesota (2016). Minnesota statues, chapter 151, section 151.252 Subd.3. Retrieved from: https://www.revisor.mn.gov/statutes/?id=151.252.
Steinman, M. A., Shlipak, M. G., & McPhee, S. J. (2001). Of principles and pens: Attitudes and practices of medicine house staff toward pharmaceutical industry promotions. The American Journal of Medicine, 110(7), 551–557.
Watson, P. Y., Khandelwal, A. K., Musial, J. L., & Buckley, J. D. (2005). Resident and faculty perceptions of conflict of interest in medical education. Journal of General Internal Medicine, 20(4), 357–359.
Weißkircher, J., Koch, C., Dreimüller, N., & Lieb, K. (2017). Conflicts of interest in medicine. A systematic review of published and scientifically evaluated curricula. GMS Journal for Medical Education, 34(3). https://doi.org/10.3205/zma001114.
Yeh, J. S., Austad, K. E., Franklin, J. M., Chimonas, S., Campbell, E. G., Avorn, J., & Kesselheim, A. S. (2015). Medical schools' industry interaction policies not associated with trainees' self-reported behavior as residents: Results of a national survey. Journal of Graduate Medical Education, 7(4), 595–602.
Funding
This study was funded by the Washington State University Mini Grant (2015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors have no conflicts of interest relevant to this article to disclose.
Rights and permissions
About this article
Cite this article
Klein, T., Graves, J. The Scope of Inclusion of Academic Conflict of Interest Policies. J Acad Ethics 16, 103–116 (2018). https://doi.org/10.1007/s10805-017-9298-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10805-017-9298-6